share_log

HC Wainwright & Co. Reiterates Buy on Tango Therapeutics, Maintains $11 Price Target

Benzinga ·  Aug 8, 2023 06:23

HC Wainwright & Co. analyst Robert Burns reiterates Tango Therapeutics (NASDAQ:TNGX) with a Buy and maintains $11 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment